Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis

Clinical and Experimental Medicine

Volumn 9, Issue 3, 2009, Pages 235-241

  Oner Iyidogan, Yildiz ^a   Oner, Pernur ^b   Kocak, Hikmet ^b   Gurdol, Figen ^b   Bekpinar, Seldag ^b   Unlucerci, Yesim ^b   Caliskan, Yasar ^a   Cetinalp Demircan, Pinar ^b   Kocak, Taner ^a   Turkmen, Aydin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

ADMA; Chronic kidney disease; Dialysis; Dimethylarginines; Inflammation; SDMA

Indexed keywords

ARGININE; DIMETHYLARGININE DERIVATIVE; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; DIMETHYLARGININE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; BLOOD; INFLAMMATION; KIDNEY FAILURE; MIDDLE AGED; PATHOLOGY; RENAL REPLACEMENT THERAPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGININE; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRIC OXIDE; RENAL DIALYSIS; RENAL INSUFFICIENCY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70349783410     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-009-0035-3     Document Type: Article

References (33)

1. F Guebre-Egziabher D Fougue 2003 Metabolic consequences of inflammation in kidney failure Nephrologie 24 383 386 14650751 1:CAS:528:DC%2BD3sXpvVyqs74%3D
2. RH Mak W Cheung 2007 Adipokines and gut hormones in end-stage renal disease Perit Dial Int 27 Suppl 2 298 302
3. F Galli 2007 Protein damage and inflammation in üremia and dialysis patients Nephrol Dial Transplant 22 Suppl 5 20 36 10.1093/ndt/gfm294
4. F Locatelli B Canaud KU Eckardt P Stenvinkel C Wanner C Zoccali 2003 Oxidative stress In end-stage renal disease: an emerging threat to patient outcome Nephrol Dial Transplant 18 1272 1280 12808161 10.1093/ndt/gfg074 1:CAS:528:DC%2BD3sXks1Wqur0%3D
5. LB Pupim J Himmelfarb E Mc Monagle Y Shyr T Ikizler 2004 Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress Kidney Int 65 2371 2375 15149350 10.1111/j.1523-1755.2004. 00656.x 1:CAS:528:DC%2BD2cXltFKgt78%3D (Pubitemid 38670023)
6. T Teerlink 2005 Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC Method Mol Med 108 263 274 1:CAS:528:DC%2BD2MXkt1Sgtbk%3D
7. T Nguyen-Khoa ZA Massy JP De Bandt, et al. 2001 Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment Nephrol Dial Transplant 16 335 340 11158409 10.1093/ndt/16.2.335 1:STN:280: DC%2BD3M7nvFyjtg%3D%3D
8. Descamps-Latscha B, Jungers P (1996) Immunological and chronic inflammatory abnormalities in end-stage renal disease. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF (eds) Replacement of renal function by dialysis. Kluwer, Dordrecht, p 1083
9. A Herbelin P Urena AT Nguyen J Zingraff B Descamps-Latscha 1991 Elevated circulating levels of interleukin-6 in patients with chronic renal failure Kidney Int 39 54 960 10.1038/ki.1991.120
10. ST Goldstein H Currier L Watters JM Hempe RD Sheth D Silverstein 2003 Acute and chronic inflammation in pediatric patients receiving hemodialysis J Pediatr 143 653 657 14615740 10.1067/S0022-3476(03)00534-1 1:CAS:528: DC%2BD3sXovVWnsLk%3D (Pubitemid 37452796)
11. O Boenisch KD Ehmke A Heddergott C Naoum U Frei R Schindler 2002 C-reactive protein and cytokine plasma levels in hemodialysis patients J Nephrol 15 547 551 12455722 1:CAS:528:DC%2BD38Xpsl2ksb4%3D
12. TMC Brunini MB Moss MAS Siqueira SFF Santos JR Lugon AC Mendes-Ribeiro 2007 Nitric oxide, malnutrition and chronic renal failure Cardiovasc Hematol Agent Med Chem 5 155 161 10.2174/187152507780363214 1:CAS:528: DC%2BD2sXktlKntL4%3D
13. J Bergström 1996 Appetite in CAPD patients Perit Dial Int 16 Suppl 1 S181 S184 8728189
14. T Shoji Y Nishizawa T Kawagishi, et al. 1997 Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis Atherosclerosis 131 229 236 9199276 10.1016/S0021- 9150(97)00054-3 1:CAS:528:DyaK2sXktF2gsLc%3D (Pubitemid 27232445)
15. M Senti R Romero J Pedro-Botet A Pelegri X Nogués J Rubies-Prat 1992 Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure Kidney Int 41 1394 1399 1614054 10.1038/ki.1992.204 1:STN:280:DyaK38zgvFOgug%3D%3D
16. K Farbakhsh BL Kasiske 2005 Dyslipidemias in patients who have chronic kidney disease Med Clin N Am 89 689 699 15755473 10.1016/j.mcna.2004.11.002 (Pubitemid 40332403)
17. C Fleck A Janz F Schweitzer E Karge M Schwertfeger G Stein 2001 Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients Kidney Int (Suppl) 78 14 18 10.1046/j.1523-1755.2001. 07817.x
18. B Marescau G Nagel I Possemiers, et al. 1997 Guanido compounds in serum and urine of nondialyzed patients with chronic renal insufficiency Metabolism 46 1024 1031 9284891 10.1016/S0026-0495(97)90273-0 1:CAS:528:DyaK2sXlslSjt7g%3D (Pubitemid 27371819)
19. JT Kielstein RH Boger SM Bode-Boger, et al. 2002 Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease J Am Soc Nephrol 13 170 176 11752034 1:CAS:528:DC%2BD38XltV2gtw%3D%3D
20. RJ Mac Allister MH Rambausek P Vallance D Williams KH Hoffmann E Ritz 1996 Concentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure Nephrol Dial Transplant 11 2449 2452 1:STN:280:DyaK2s7ntVSqsA%3D%3D
21. JT Kielstein SR Salpater SM Bode-Boger JP Cooke D Fliser 2006 Symmetric dimethylarginine (SDMA) as endogenous marker of renal function-a meta analysis Nephrol Dial Transplant 21 2446 2451 16766542 10.1093/ndt/gfl292 1:CAS:528:DC%2BD28XhtVWlt7%2FI (Pubitemid 44644516)
22. JM Leiper P Vallance 2006 The synthesis and metabolism of asymmetric dimethylarginine (ADMA) Eur J Clin Pharmacol 62 33 38 10.1007/s00228-005-0013-y
23. B Anderstam Bergström J Katzarski 1997 Serum levels of NG, NG-dimethyl-l-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients J Am Soc Nephrol 8 1437 1442 9294836 1:CAS:528: DyaK2sXmtl2murk%3D
24. M Al Banchaabouchi B Marescau I Possemiers R D'Hooge O Levillain PP De Deyn 2000 NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency Pflugers Arch 439 524 531 10764210 10.1007/s004240050973 1:CAS:528:DC%2BD3cXhvFCns7w%3D (Pubitemid 30140143)
25. DE Wilcken J Wang AS Sim K Green B Wilcken 2006 Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function J Inherit Metab Dis 29 30 37 16601865 10.1007/s10545-006-0208-0 1:CAS:528:DC%2BD28XjtlWgurg%3D
26. R Jofré P Rodriguez-Benitez JM Lopez-Gomez R Pérez-Garcia 2006 Inflammatory syndrome in patients on hemodialysis J Am Soc Nephrol 17 274 280 10.1681/ASN.2006080926 (Pubitemid 44865261)
27. KY Lin A Ito T Asagami PS Tsao S Adimoolam M Kimoto H Tsuji GM Reaven JP Cooke 2002 Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase Circulation 106 987 992 12186805 10.1161/01.CIR.0000027109.14149.67 1:CAS:528:DC%2BD38XntlSqs70%3D (Pubitemid 34925335)
28. S Xiao RJ Schmidt C Baylis 2000 Plasma from ESRD patients inhibits nitric oxide synthase (NOS) activity in cultured human and bovine endothelial cells Acta Phys Scand 168 175 179 10.1046/j.1365-201x.2000.00640.x 1:CAS:528:DC%2BD3cXhvVelt7k%3D (Pubitemid 30128685)
29. K Yokokawa R Mankus MG Saklayen, et al. 1995 Increased nitric oxide production in patients with hypotension during hemodialysis Ann Intern Med 123 35 37 7762912 1:STN:280:DyaK2M3otlWlsA%3D%3D
30. T Lau W Owen YM Yu, et al. 2000 Arginine, citrulline and nitric oxide metabolism in end-stage renal disease patients J Clin Invest 105 1217 1225 10791996 10.1172/JCI7199 1:CAS:528:DC%2BD3cXivFKgtr8%3D
31. AC Mendes-Ribeiro TMC Brunini JC Ellory GE Mann 2001 Abnormalities in l-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure Cardiovasc Res 49 697 712 11230969 10.1016/S0008-6363(00)00267-4 1:CAS:528:DC%2BD3MXhsVOitbw%3D (Pubitemid 32178373)
32. RC Thuraisingham NB Roberts M Wilkes DI New AC Mendes-Ribeiro SM Dodd MM Yaquoob 2002 Altered l-arginine metabolism results in increased nitric oxide release from uremic endothelial cells Clin Sci 103 31 41 12095401 10.1042/CS20010348 1:CAS:528:DC%2BD38XmtVSrsrg%3D
33. A Gutierrez 1996 Protein catabolism in maintenance haemodialysis: the influence of the dialysis membrane Nephrol Dial Transplant 11 108 111 8804008